
Screening - Invasive Ductal Carcinoma (IDC) (USA)
How can suspicious findings in screening be followed up with DBT?
Subtle cancers in fatty breasts: FDM, IN2D, DBT, US, MR.
63 year old lady with a previous history of bilateral reduction and no symptoms. You can see the conventional mammograms. This is a fatty pattern A. And no lesions are detected. However. Emphasis need detective as subtle irregular mass in the left breast, as you can see in this image. And if we focus? This lesion can see that. The conventional to the view is normal. But. On the tour mode you can see the irregular mass. Indistinct mass. The correlation. With ultrasound is shown. As well as the correlation with MRI. And the final result was an invasive ductal cancer luminal, a subtype. And the size was 3.5 millimeters. So. The conclusion of this case is that tomosynthesis is capable of detecting. Septum cancers, even inflating breasts.
12/27/2017 1/1/2022 13 Screening 1 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS 04_Screening_1. PID3626 * 1/1/2022 F PID3626 RMLO LMLO Series Navigator PID3626 Add Study 12/1/2017 (Study date) Current Current Current LCC INSIGHT_2D_RCC TRCC TLCC Viewing Favorite Layouts US MR DYN MR.Dyna ... MR.Empty ReportFlow BASIC Printing Tools Findings MR 3:07 PM Clinical information 63-year-old female Previous history of bilateral reduction No symptoms Healthineers TLMLO/TLML not found. Slice 29 / 67 Slice 28 / 72 lige thickness: 1.00 mm Slice thickness 1.00 mm SIEMENS . PC.MLOICC Slice 29 / 72 Slice thickness: 1.00 mm C.CC 1/1/2022, F check 10:29:09 AM ultrasound 12/1/2017 (Study date) B RES-B 1976 IMA 53 P 44mm PRC 12/2/1 PRS 4 PST PINA LA523 D1 0.35 Cm Reset WIL Reset Custom Text Graphics Marker SP H45.8 SL 1.5 mm p2 9:56 PM XV 6 Layout DR. PINA mm 3:08 PM Pathology Invasive ductal carcinoma (IDC) Luminal A, 3.5 mm Conclusion DBT can detect subtle cancers even in fatty breasts. LCC Series Navigator Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. Hec
- dbt
- in2d
- cyst
- radial
- contralateral
- cancer
- fatty